Predpokladaný rast EPS Q/Q spoločnosti Cue Biopharma Inc
Aká je hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Cue Biopharma Inc?
Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Cue Biopharma Inc je 36.00%
Aká je definícia metriky Predpokladaný rast EPS Q/Q?
Očakávaný rast EPS (Estimated quarterly EPS growth rate) z roka na rok je predpokladaný rast EPS spoločnosti za ďaľší kvartál v porovnaní s výsledkami z minulého kvartálu.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Predpokladaný rast EPS Q/Q spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Cue Biopharma Inc
Čomu sa venuje spoločnosť Cue Biopharma Inc?
cue biopharma is an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. we design biologics to engage and modulate the activity of disease-associated t cells in the patient’s body, offering significant therapeutic advantages while potentially minimizing or eliminating unwanted side effects. we believe our biologics allow us to target antigen-specific t cell populations in a variety of indications using a simple peptide exchange within previously-validated drug frameworks developed from the cue biologics platform. this flexibility could truncate the drug selection and development process, moving effective therapeutics from discovery to clinical validation more rapidly and cost efficiently than current industry standard timelines and costs. headquartered in kendall square, cambridge, ma, we are led by an experienced management team and sci
Firmy s metrikou predpokladaný rast eps q/q podobnou spoločnosti Cue Biopharma Inc
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Moog je 35.51%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Byline Bancorp Inc je 35.56%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti LIC Housing Finance je 35.56%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Enservco Corp je 35.71%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Chargepoint je 35.71%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti ZTO Express (Cayman) Inc je 35.71%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Cue Biopharma Inc je 36.00%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Varun Beverages je 36.11%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti RB Global Inc je 36.11%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Airbus SE je 36.21%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti AIA Engineering je 36.25%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti West Fraser Timber Co je 36.30%
- Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Avis Budget Inc je 36.31%